Mycophenolate mofetil for prevention of acute rejection.
Moore
R
R
Griffin
P
P
Darby
C
C
Jurewicz
A
A
Lord
R
R
D000208:Acute Disease; D000328:Adult; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control* / Q000628:therapy; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects / Q000502:physiology; D016030:Kidney Transplantation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D009173:Mycophenolic Acid; D008775:Methylprednisolone